Skip to main content
$221.51 $6.04 (2.8%)

01:26 PM EST on 01/19/21

Repligen Corp (NASDAQ:RGEN)

CAPS Rating: 5 out of 5

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Current Price $221.51 Mkt Cap $11.7B
Open $220.56 P/E Ratio 257.02
Prev. Close $215.47 Div. (Yield) $0.00 (0.0%)
Daily Range $217.44 - $226.53 Volume 337,931
52-Wk Range $78.41 - $226.53 Avg. Daily Vol. 400,891

Caps

How do you think NASDAQ:RGEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

603 Outperform
14 Underperform
 

All-Star Players

221 Outperform
4 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jlouko72 (76.96)
Submitted October 01, 2020

originally had this at 140 so im adding 7% in my head :)

Skyshadow664 (< 20)
Submitted June 14, 2012

These medical corporations tend to have spurts of large growth with long periods of notable decline. Just as Genetic Technologies as been fluctuating over the past year (a range from ~$2.50 - ~$10.00), this company follows a very similar trend. It… More

NASDAQ:RGEN VS S&P 500 (SPY)

Fools bullish on NASDAQ:RGEN are also bullish on:

Fools bearish on NASDAQ:RGEN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RGEN.

Recs

0
Member Avatar TMFjbonefish (52.34) Submitted: 1/13/2021 2:26:37 PM : Outperform Start Price: $209.36 NASDAQ:RGEN Score: +6.03

Long-term tailwind: Industry shifting to single-use systems
Short-term tailwind: COVID-related demand

Recs

0
Member Avatar yerkej (62.05) Submitted: 11/27/2020 11:57:49 PM : Outperform Start Price: $183.21 NASDAQ:RGEN Score: +16.17

"Picks and shovels" company that will capitalize on the shift in pharmaceuticals away from small molecular drugs to monoclonal antibodies (even drugs for things as common as migraines are starting to be developed in this way).

Recs

0
Member Avatar ButchSooner (88.42) Submitted: 11/12/2020 2:57:58 PM : Outperform Start Price: $207.23 NASDAQ:RGEN Score: -1.11

Future biotech winner

Leaderboard

Find the members with the highest scoring picks in RGEN.

Score Leader

Stevegoldenfool

Stevegoldenfool (< 20) Score: +6,530.31

The Score Leader is the player with the highest score across all their picks in RGEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Stevegoldenfool < 20 9/26/2011 Outperform 5Y $3.22 +6,760.87% +230.56% +6,530.31 0 Comment
TXawlman 96.05 10/26/2006 Outperform 5Y $3.37 +6,457.44% +190.45% +6,266.99 1 Comment
toroandbruin 70.92 10/25/2006 Outperform 1Y $3.37 +6,455.49% +190.79% +6,264.70 0 Comment
sincroton < 20 8/25/2006 Outperform 1Y $3.36 +6,475.00% +211.70% +6,263.30 1 Comment
warbucks52 < 20 8/25/2006 Outperform 1Y $3.36 +6,475.00% +211.85% +6,263.15 0 Comment
marky985 < 20 10/27/2008 Outperform 3Y $3.32 +6,554.22% +349.38% +6,204.84 0 Comment
youmustwhipit 55.45 10/27/2008 Outperform NS $3.32 +6,554.22% +349.38% +6,204.84 0 Comment
runic42 92.79 10/2/2006 Outperform 1Y $3.40 +6,397.65% +201.18% +6,196.46 0 Comment
Vanter1 99.18 11/11/2011 Outperform 5Y $3.41 +6,378.59% +198.90% +6,179.69 0 Comment
wonderpiks 77.43 5/6/2010 Outperform 5Y $3.42 +6,359.65% +225.87% +6,133.78 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RGEN.